Tag: nasdaq:abeo

December 9, 2019

Abeona Therapeutics to Initiate Phase 3 Clinical Trial of B-101

The company announced that the US Food and Drug Administration has removed its clinical hold on its Phase 3 clinical...
September 23, 2019

Abeona to Submit More Data to FDA Before Starting Phase 3 Trial

Following the announcement, shares of Abeona Therapeutics tumbled nearly 12 percent in Monday's trading session.
September 8, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Abeona Rises 66 Percent

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
June 18, 2019

Abeona Therapeutics Receives FDA Fast Track Designation for ABO-202 AAV9 Gene Therapy

Abeona Therapeutics (NASDAQ:ABEO) has announced that the US Food and Drug Administration (FDA) has granted the company fast track designation...
April 30, 2019

Abeona Therapeutics Presents New Preclinical Data of ABO-401

Abeona Therapeutics announced the presentation of new preclinical data on its candidate ABO-401.
December 7, 2018

Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs

Abeona Therapeutics (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic...